
GOAL.MD Review
Best for: manual-renewal billing with dose-tiered brand-name pricing transparency
GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing — paired with transparent, dose-tiered brand pen pricing and a free nutrition coach. Compounded semaglutide starts at $179/mo; brand Ozempic and Wegovy from $294/mo, Zepbound from $394/mo.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
GOAL.MD is a solid telehealth option with balanced features and pricing.
GOAL.MD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Wegovy, Ozempic, Zepbound
- Starting price
- $179/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored GOAL.MD
Each dimension is scored algorithmically from GOAL.MD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.7/10At $179/mo, GOAL.MD runs about 5% above the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
6.9/10GOAL.MD offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
5.9/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
5.5/10Some details we couldn't independently confirm; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-03).
Accessibility10%
6.8/10GOAL.MD treats patients in all 50 states.
Support10%
6.3/10Coaching/dietitian access included.
How we verified this GOAL.MD review
Last checked 2026-06-03- Confirmed current pricing across 8 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: low.
GLP-1 medications GOAL.MD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check GOAL.MD's current pricing and active discounts before you decide.
What we like
- Transparent dose-tiered pricing on brand pens
- LegitScript Certified
- Manual-renewal model — no surprise auto-billing
- Free nutrition coach included
- BBB A+ rating since 2021
Watch-outs
- No named compounding pharmacy partner
- Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
- No URAC or PCAB pharmacy accreditation
GOAL.MD in one line: a no-auto-billing model with a leadership problem you should know about
GOAL.MD is a St. Louis telehealth brand (legally Jellyfish LLC) that sells compounded semaglutide alongside brand-name pens — Ozempic, Wegovy, and Zepbound. Two things genuinely stand out about it, one good and one serious. The good: it bills manually, so you renew when you choose instead of getting hit by surprise auto-charges. The serious: its named chief physician and co-founder has a 2016 federal guilty plea tied to misbranded HGH, and the company won't name the pharmacy that compounds your medication. Those are not small details for a drug you inject, and they're why we rate our confidence in GOAL.MD low. This review walks through exactly what you're getting and what you're trusting.
How the pricing actually works — and where it's drifting
Compounded semaglutide is advertised from $179 a month, but read the fine print: that figure is the per-month rate when you buy a three-month bundle. Pay month to month and it runs closer to two hundred dollars. Pricing is flat across doses — you don't pay more as your dose climbs, which is a real advantage over providers that raise the price at every titration step. For context, the category median we track sits at $170, so GOAL.MD's compounded entry price is roughly in line with the middle of the market, not a standout bargain.
The brand-pen pricing is where GOAL.MD historically scored points: it published dose-tiered rates instead of hiding them, with Ozempic, Wegovy, and Zepbound listed by specific pen and dose. Be aware, though, that the company appears to be moving to a different brand model — a flat membership-style fee plus the medication cost billed separately — so the older per-pen numbers may no longer match what you're quoted. Confirm the current brand price directly with GOAL.MD before you commit; this is an area in active flux.
- Flat dosing: one price regardless of how high your dose goes
- Manual renewal: no auto-billing, no subscription trap — you re-order deliberately
- Bundle math matters: the headline $179 assumes a multi-month purchase; single months cost more
- Brand pricing is shifting: verify the current model before assuming the old dose-tiered rates
What's included for the money
A plan covers the medication, your physician consultation, ongoing monitoring, and free expedited shipping, with — per GOAL.MD's own site — no hidden fees. A free nutrition coach is bundled in, which is a nicer touch than most low-cost compounders bother with. Coverage is nationwide across all 50 states. On paper that's a complete package, and the company carries a LegitScript certification and a BBB A+ rating dating to 2021, both of which are legitimate positive signals.
The medication question: who actually makes your compound?
Here's the first real problem. When you buy compounded semaglutide, the pharmacy that mixes it matters enormously — it's the entity responsible for sterility, dosing accuracy, and sourcing. GOAL.MD does not name that pharmacy. Its pharmacy page refers only to 'a vetted network of FDA-registered pharmacies,' with no individual facility named and no URAC or PCAB pharmacy accreditation disclosed. Our editorial standard treats a named, accredited pharmacy partner as a baseline requirement for a medium-or-higher trust rating, and GOAL.MD doesn't meet it. You're being asked to trust an unnamed supplier for an injectable drug.
The leadership disclosure you won't see advertised
This is the bigger issue, and it's a matter of public court record. GOAL.MD's listed Chief Physician and Co-Founder, Dr. Michael 'Ted' Mimlitz, pleaded guilty in April 2016 in U.S. District Court for the Eastern District of Missouri to distributing misbranded, Mexican-sourced human growth hormone to roughly 40 patients. He was sentenced to probation, fined, and ordered to forfeit funds; the Missouri medical board revoked his license and then reinstated it on a two-year probation. As of our most recent check he was still listed as Chief Physician and Co-Founder on the company's about page. We found no FDA warning letters against GOAL.MD or its parent Jellyfish LLC, and no public record of further board discipline since the 2017 reinstatement — but a federal misbranding conviction in the very category this company operates in (prescription injectables) is exactly the kind of thing a patient deserves to weigh before signing up.
Why this combination matters more than either fact alone
An unnamed compounding pharmacy is a yellow flag on its own. A chief physician with a misbranded-drug conviction is a yellow flag on its own. Together, on a platform shipping injectable medication, they compound into something we can't wave past. None of this is alleged — it's drawn from federal court records and the company's own website.
Who GOAL.MD is for — and who should walk
There's a narrow group this could suit: someone who specifically wants to avoid auto-billing subscriptions, values flat dose pricing, and is comfortable doing their own due diligence on the leadership and pharmacy questions above. The manual-renewal model is genuinely consumer-friendly, and nationwide coverage plus an included nutrition coach are real perks.
- Consider it if: you want manual renewal over auto-billing and flat pricing as your dose increases, and you've read and accepted the trust caveats
- Skip it if: a named, accredited compounding pharmacy is non-negotiable for you
- Skip it if: the chief physician's federal misbranding conviction gives you pause — a reasonable reaction
- Skip it if: you want brand-pen pricing you can lock in, given the model is currently shifting
Bottom line
GOAL.MD does some things right — no surprise billing, flat dosing, free shipping and coaching, LegitScript and BBB credentials, and historically honest brand-pen price tables. But the things it does right are bookkeeping conveniences, while the things working against it go to the core of safety: who makes your medication, and who's medically in charge. Until GOAL.MD names an accredited compounding pharmacy and resolves the questions around its chief physician's standing, we keep our confidence rating low and suggest most readers compare it against providers that clear those bars before deciding. If you do proceed, confirm the current pricing and the pharmacy in writing first. You can read how we weigh these factors in our scoring methodology.
Worth pricing against Sunlight ($159/month) and Bodybuilding Health+ ($179/month) before you commit — both sit close to GOAL.MD on cost and formulation.
Ready to start with GOAL.MD?
Starting at $179/month. See current pricing and start your free consultation.
Alternatives to GOAL.MD
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this GOAL.MD review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Ready to start with GOAL.MD?
Starting at $179/month. See current pricing and start your free consultation.